<!DOCTYPE html>
<html lang="en">

<head>
  <!-- Title -->
  <title>Top News in Peptides - Q2 2024</title>

  <!-- Required Meta Tags Always Come First -->
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta http-equiv="x-ua-compatible" content="ie=edge">

  <!-- Favicon -->
  <link rel="shortcut icon" href="../assets/img/favicon.png">
  <!-- Google Fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans:300,400,600,700,800">
  <!-- CSS Global Compulsory -->
  <link rel="stylesheet" href="../assets/vendor/bootstrap/bootstrap.min.css">
  <link rel="stylesheet" href="../assets/vendor/icon-awesome/css/font-awesome.min.css">
  <link rel="stylesheet" href="../assets/vendor/icon-line-pro/style.css">
  <link rel="stylesheet" href="../assets/vendor/icon-line/css/simple-line-icons.css">
  <link rel="stylesheet" href="../assets/vendor/icon-hs/style.css">
  <link rel="stylesheet" href="../assets/vendor/animate.css">
  <link rel="stylesheet" href="../assets/vendor/fancybox/jquery.fancybox.css">
  <link rel="stylesheet" href="../assets/vendor/hs-megamenu/src/hs.megamenu.css">
  <link rel="stylesheet" href="../assets/vendor/hamburgers/hamburgers.min.css">

  <!-- CSS Unify -->
  <link rel="stylesheet" href="../assets/css/unify-core.css">
  <link rel="stylesheet" href="../assets/css/unify-components.css">
  <link rel="stylesheet" href="../assets/css/unify-globals.css">

  <!-- CSS Customization -->
  <link rel="stylesheet" href="../assets/css/custom.css">

  <!-- Paste the Mailchimp CSS link in the <head> of your HTML file -->
<link href="//cdn-images.mailchimp.com/embedcode/classic-061523.css" rel="stylesheet" type="text/css">

</head>

<body>
  <main>



      <!-- Header -->
      <header id="js-header" class="u-header u-header--static">
        <div class="u-header__section u-header__section--light g-bg-white g-transition-0_3 g-py-10">
<nav class="js-mega-menu navbar navbar-expand-lg hs-menu-initialized hs-menu-horizontal">
  <div class="container">

              <!-- Responsive Toggle Button -->
              <button class="navbar-toggler navbar-toggler-right btn g-line-height-1 g-brd-none g-pa-0 g-pos-abs g-top-minus-3 g-right-0" type="button" aria-label="Toggle navigation" aria-expanded="false" aria-controls="navBar" data-toggle="collapse" data-target="#navBar">
                <span class="hamburger hamburger--slider">
              <span class="hamburger-box">
                <span class="hamburger-inner"></span>
                </span>
                </span>
              </button>
              <!-- End Responsive Toggle Button -->
  
              <!-- Logo -->
              <a href="../index.html" class="navbar-brand d-flex me-auto">
                  <img width="46px" height="46px" src="../assets/img/favicon.png">
              </a>
                <!-- End Logo -->
  
              <!-- Navigation -->
<div class="collapse navbar-collapse align-items-center flex-sm-row g-pt-10 g-pt-5--lg" id="navBar">
  <ul class="navbar-nav text-uppercase g-pos-rel g-font-weight-600">

                  <!-- Home -->
                  <li class="nav-item  g-mx-10--lg g-mx-15--xl">
                    <a href="../index.html" class="nav-link g-py-7 g-px-0">Home</a>
                  </li>
                  <!-- End Home -->

                     <!-- Research Scale -->
                <li class="hs-has-sub-menu nav-item  g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                  <a id="nav-link-pages" class="nav-link g-py-7 g-px-0" href="../researchscale.html" aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu-pages">Research Peptide Synthesizers</a>
                  
                  <ul class="hs-sub-menu list-unstyled u-shadow-v11 g-brd-top g-brd-primary g-brd-top-2 g-min-width-220 g-mt-18 g-mt-8--lg--scrolling" id="nav-submenu-pages" aria-labelledby="nav-link-pages">
                    <!-- Pages - CSBio II -->
                    <li class="dropdown-item">
                      <a id="nav-link--pages--peptidesyn" class="nav-link" href="../csbioii.html" aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--pages--peptidesyn">CSBio II</a>
                    </li>
                    <!-- End Pages - CSBio II  -->

                    <!-- Pages - CS136X -->
                    <li class="dropdown-item">
                      <a id="nav-link--pages--dnasyn" class="nav-link" href="../136x.html" aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--pages--dnasyn">CS136X</a>
                    </li>
                    <!-- End Pages - CS136X -->

                    <!-- Pages - CS136M -->
                    <li class="dropdown-item">
                      <a id="nav-link--pages--purf" class="nav-link" href="../136M.html" aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--pages--purf">CS136M</a>
                    </li>
                    <!-- End Pages - CS136M -->
                  </ul>
                </li>
    <!-- End Research Scale  -->
  
                  <!-- Pilot Scale -->
                  <li class="nav-item hs-has-sub-menu  g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                    <a id="nav-link--features" class="nav-link g-py-7 g-px-0" href="../pilotscale.html" aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--features">Pilot Peptide Synthesizers</a>
  
                    <ul class="hs-sub-menu list-unstyled u-shadow-v11 g-brd-top g-brd-primary g-brd-top-2 g-min-width-220 g-mt-18 g-mt-8--lg--scrolling" id="nav-submenu--features" aria-labelledby="nav-link--features">
                      <!--  CS536X -->
                      <li class="dropdown-item ">
                        <a class="nav-link" href="../536x.html">CS536X</a>
                      </li>
                      <!-- End  CS536X -->
                      <!-- CS936S -->
                      <li class="dropdown-item ">
                        <a class="nav-link" href="../936s.html">CS936S</a>
                      </li>
                      <!-- End CS936S -->
                    </ul>
                  </li>
                  <!-- End Pilot Scale -->

                   <!-- Commercial Scale -->
                   <li class="nav-item g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                    <a href="../commercialscale.html" id="nav-link--features" class="nav-link g-py-7 g-px-0"  aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--features">Commercial Peptide Synthesizers</a>
                  </li>
                  <!-- End Commercial Scale -->

                   <!-- DNA Synthesizers -->
                   <li class="nav-item g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                    <a href="../dna.html" id="nav-link--features" class="nav-link g-py-7 g-px-0"  aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--features">DNA Synthesizers</a>
                  </li>
                  <!-- End Blog -->

  
                   <!-- Blog -->
                   <li class="nav-item g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                    <a href="../blog.html" id="nav-link--features" class="nav-link g-py-7 g-px-0"  aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--features">Resources</a>
                  </li>
                  <!-- End Blog -->


                   <!-- About -->
                   <li class="nav-item hs-has-sub-menu  g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                    <a id="nav-link--features"  class="nav-link g-py-7 g-px-0" href="../offices.html" aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--features">About</a>
  
                    <ul class="hs-sub-menu list-unstyled u-shadow-v11 g-brd-top g-brd-primary g-brd-top-2 g-min-width-220 g-mt-18 g-mt-8--lg--scrolling" id="nav-submenu--features" aria-labelledby="nav-link--features">
                      <!-- Contact - Offices -->
                      <li class="dropdown-item ">
                        <a class="nav-link" href="../offices.html">Company Overview</a>
                      </li>
                      <!-- End Features - Offices -->

                      <!-- Features - Careers -->
                      <li class="dropdown-item ">
                        <a class="nav-link" href="../offices.html#locations">Our Locations</a>
                      </li>
                      <!-- End Features - Careers -->

  
                    </ul>
                  </li>
                  <!-- End Contact -->

                                                           <!-- Info -->
                     <li class="nav-item g-mx-10--lg g-mx-15--xl" data-animation-in="fadeIn" data-animation-out="fadeOut">
                      <a href="../quotesynthesizer.html" id="nav-link--features" class="nav-link g-py-7 g-px-0"  aria-haspopup="true" aria-expanded="false" aria-controls="nav-submenu--features"><Strong><font color="#2f3192">Request Synthesis Equipment</Strong></font></a>
                    </li>
                    <!-- End Info -->


                </ul>
              </div>
              <!-- End Navigation -->
            </div>
          </nav>
        </div>
      </header>
      <!-- End Header -->

    <!-- Blog Single Item Banner -->
    <section class="g-bg-cover g-bg-size-cover g-bg-white-gradient-opacity-v1--after" data-bg-img-src="../../assets/img-temp/1920x1080/img1.jpg">
      <div class="container text-center g-pos-rel g-z-index-1 g-pb-50">
        <div class="row d-flex justify-content-center align-content-end flex-wrap g-min-height-300">
          <div class="col-lg-7 mt-auto">
            <div class="mb-5">
              <h1 class="g-color-white g-font-weight-600 g-mb-30">The Latest News in the Peptide World</h1>
              <p class="lead g-color-white-opacity-0_6">Q2 2024 Edition</p>
            </div>
          </div>
        </div>
      </div>
    </section>
    <!-- End Blog Single Item Banner -->

    <!-- Blog Single Item Info -->
    <section class="container g-pt-100 g-pb-60">
      <div class="row justify-content-center">
        <div class="col-lg-9">

          <div class="g-mb-60">

            <p><span class="d-inline-block float-left g-width-60 g-height-60 g-color-black g-font-weight-600 g-font-size-30 text-center g-pa-7 mr-2">W</span>elcome to our Q2 2024 Peptide News Roundup! This quarter has been groundbreaking for the peptide space, with major strides in corporate partnerships, cutting-edge research, and technological innovations. We're changing our format slightly, and doing a quarterly review and dividing it into two exciting sections: the first set of articles showcases notable industry news and clinical advancements, including major moves by Novartis and Eli Lilly. The second set delves into scientific breakthroughs and innovative technologies that are pushing the boundaries of peptide research. Dive in to discover how these developments are shaping the future of medicine and biotechnology!</p>
          </div>

<div class="g-mb-60" style="display: flex; justify-content: center; align-items: center; flex-direction: column; text-align: center;">
  <h3 class="h4 g-color-black g-font-weight-600"><span class="g-font-size-25">Industry News and Clinical Advancements</span></h3>
</div>


    
<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">01.</span> 
    Novartis Pays PeptiDream $180M as Radiopharma Big Bang Continues
  </h3>
  <p>
    Novartis expands its peptide-drug conjugate (PDC) collaboration with PeptiDream by investing $180 million. This partnership focuses on developing targeted radiotherapy treatments for cancer using PDC technology.
  </p>
  <a class="g-font-size-13" href="https://www.fiercebiotech.com/biotech/novartis-pays-peptidream-180m-radiopharma-big-bang-continues">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">02.</span> 
    Lilly Signs $140M Upfront Partnership with Radiopharmaceutical Company
  </h3>
  <p>
    Eli Lilly enters a $140 million upfront deal with Radiopharmaceuticals to develop innovative cancer therapies, aligning with its strategy to expand its radiopharmaceutical portfolio.
  </p>
  <a class="g-font-size-13" href="https://www.fiercebiotech.com/biotech/lilly-signs-140m-upfront-partnership-radionectics-latest-radiopharma-play">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">03.</span> 
    Health Tech Startup Dandelion Health Launches Data Library
  </h3>
  <p>
    Dandelion Health launches a comprehensive data library aimed at accelerating insights into GLP-1 drugs, supporting advancements in personalized medicine through extensive datasets.
  </p>
  <a class="g-font-size-13" href="https://www.fiercehealthcare.com/health-tech/health-tech-startup-dandelion-health-launches-data-library-advance-insights-glp-1-drugs">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">04.</span> 
    KU Cancer Center Researcher Secures $1.4M Grant for Peptide Therapy
  </h3>
  <p>
    A KU Cancer Center researcher secures a $1.4 million grant to develop a peptide therapy for prostate cancer, supporting preclinical studies for this innovative treatment.
  </p>
  <a class="g-font-size-13" href="https://www.newswise.com/articles/ku-cancer-center-researcher-secures-1-4m-grant-to-develop-peptide-therapy-for-prostate-cancer">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">05.</span> 
    Eli Lilly's Tirzepatide Scores Again in Sleep Apnea Trials
  </h3>
  <p>
    Eli Lilly's tirzepatide shows positive results in sleep apnea trials, demonstrating its potential to treat multiple conditions, including diabetes and obesity.
  </p>
  <a class="g-font-size-13" href="https://www.fiercepharma.com/pharma/eli-lillys-tirzepatide-scores-again-time-2-sleep-apnea-trials">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">06.</span> 
    Entera Bio to Present Phase 1 Data and Achieves Regulatory Milestone for PTH 1-34 Peptide Tablets
  </h3>
  <p>
    Entera Bio will present phase 1 data for its PTH1-34 peptide tablets for hypoparathyroidism at the ENDO 2024 conference, aiming to offer a convenient treatment option. Additionally, Entera Bio achieves a regulatory milestone for its oral PTH 1-34 peptide, EB613, with the FDA expected to rule on qualifying bone mineral density as a surrogate endpoint within 10 months.
  </p>
  <a class="g-font-size-13" href="https://www.morningstar.com/news/globe-newswire/9116197/entera-bio-to-present-phase-1-data-from-first-in-class-pth1-34-peptide-tablets-eb612-for-the-treatment-of-hypoparathyroidism-at-endo-2024">Read more...</a> <br/>
  <a class="g-font-size-13" href="https://www.biospace.com/article/releases/entera-bio-announces-key-regulatory-milestone-for-oral-pth-1-34-peptide-eb613-phase-3-program-fda-ruling-on-qualifying-bmd-as-a-surrogate-endpoint-for-osteoporosis-drugs-is-expected-within-10-months/">and here...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">07.</span> 
    Darling Ingredients Identifies Collagen Peptide Profiles for Targeted Health Benefits
  </h3>
  <p>
    Darling Ingredients has identified specific collagen peptide profiles that offer targeted health benefits. These findings could lead to the development of new supplements and treatments aimed at improving joint health, skin elasticity, and overall well-being (Source: PR Newswire).
  </p>
  <a class="g-font-size-13" href="https://www.prnewswire.com/news-releases/darling-ingredients-inc-identifies-collagen-peptide-profiles-for-targeted-health-benefits-302114817.html">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">08.</span> 
    Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy
  </h3>
  <p>
    Treos Bio will present phase 2 trial results of PolyPEPI1018 combined with Rocheâ€™s PD-L1 inhibitor for treating metastatic colorectal cancer at the 2024 ASCO Annual Meeting.
  </p>
  <a class="g-font-size-13" href="https://www.morningstar.com/news/globe-newswire/9113276/treos-bio-to-present-new-clinical-data-on-off-the-shelf-peptide-immunotherapy-for-colorectal-cancer-at-2024-asco-annual-meeting">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">09.</span> 
    Metsera Secures $290M in Funding, Focuses on Customizable Combos for Obesity
  </h3>
  <p>
    Metsera raises $290 million to develop customizable combination therapies for obesity, aiming to tailor treatments to individual patient needs.
  </p>
  <a class="g-font-size-13" href="https://www.fiercebiotech.com/biotech/290m-hand-newly-emerged-biotech-metsera-thinks-customizable-combos-are-future-obesity">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">10.</span> 
    Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration
  </h3>
  <p>
    Secarna Pharmaceuticals and Orbit Discovery are collaborating to develop peptide-conjugated targeted antisense oligonucleotide therapeutics, combining their strengths in peptide and oligonucleotide technologies.
  </p>
  <a class="g-font-size-13" href="https://www.morningstar.com/news/business-wire/20240528575483/secarna-pharmaceuticals-and-orbit-discovery-enter-collaboration-to-discover-and-develop-peptide-conjugated-targeted-antisense-oligonucleotide-therapeutics">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">11.</span> 
    NeuroBo Pharmaceuticals Doses First Patient in Phase 1 Obesity Trial
  </h3>
  <p>
    NeuroBo Pharmaceuticals begins dosing in its phase 1 trial evaluating DA-1726 for obesity, assessing the safety and efficacy of this novel peptide drug.
  </p>
  <a class="g-font-size-13" href="https://www.biospace.com/article/releases/neurobo-pharmaceuticals-doses-first-patient-in-the-mad-part-2-of-its-phase-1-clinical-trial-evaluating-da-1726-for-the-treatment-of-obesity/">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">12.</span> 
    Viking Touts Promising Phase 1 Data for Weight Loss Pill
  </h3>
  <p>
    Viking Therapeutics announces promising phase 1 trial results for its weight loss pill, showing significant weight reduction in participants.
  </p>
  <a class="g-font-size-13" href="https://www.biospace.com/article/viking-touts-promising-phase-i-data-for-weight-loss-pill/">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">13.</span> 
    Donaldson and PolyPeptide Partner to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology
  </h3>
  <p>
    Donaldson and PolyPeptide have partnered to enhance sustainability in peptide manufacturing through solvent recovery technology. This collaboration aims to reduce environmental impact and improve efficiency in the production process, aligning with industry trends towards greener practices.
  </p>
  <a class="g-font-size-13" href="https://markets.ft.com/data/announce/detail?dockey=600-202405131612BIZWIRE_USPRX____20240513_BW059583-1">Read more...</a>
</div>

<div class="g-mb-60" style="display: flex; justify-content: center; align-items: center; flex-direction: column; text-align: center;">
  <h3 class="h4 g-color-black g-font-weight-600"><span class="g-font-size-25">Scientific Breakthroughs</span></h3>
</div>


<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">01.</span> 
    UW's Baker Lab Researchers Make AI Strides in Drug Peptides
  </h3>
  <p>
    UW's Baker Lab researchers use AI to advance the development of drug peptides, potentially revolutionizing the drug discovery process.
  </p>
  <a class="g-font-size-13" href="https://www.fiercebiotech.com/medtech/uws-baker-lab-researchers-make-ai-strides-drug-peptides">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">02.</span> 
    Aligned Peptide Noodles Could Enable Lab-Grown Biological Tissues
  </h3>
  <p>
    Researchers have developed aligned peptide structures, referred to as "peptide noodles," which could be instrumental in creating lab-grown biological tissues. These structures provide the necessary scaffolding for tissue engineering, advancing the field of regenerative medicine (Source: Rice University).
  </p>
  <a class="g-font-size-13" href="https://news.rice.edu/news/2024/aligned-peptide-noodles-could-enable-lab-grown-biological-tissues">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">03.</span> 
    Engineered Peptides Show Promise in Cancer Immunotherapy
  </h3>
  <p>
    Engineered peptides are proving to be effective in enhancing the immune system's ability to target and destroy cancer cells, offering new potential in cancer immunotherapy.
  </p>
  <a class="g-font-size-13" href="https://www.news-medical.net/news/20240422/Engineered-peptides-show-promise-in-cancer-immunotherapy.aspx">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">04.</span> 
    Bone-Enhancing Peptide Shows Promise as Therapeutic
  </h3>
  <p>
    Research on a bone-enhancing peptide shows promise for treating osteoporosis and musculoskeletal disorders by stimulating bone growth.
  </p>
  <a class="g-font-size-13" href="https://www.genengnews.com/topics/drug-discovery/bone-enhancing-peptide-shows-promise-as-therapeutic-for-osteoporosis-and-msk-disorders/">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">05.</span> 
    Revolutionizing Cysteine-Rich Peptide Production for Drug Discovery
  </h3>
  <p>
    A new method for producing cysteine-rich peptides could significantly advance drug discovery by overcoming previous synthesis challenges.
  </p>
  <a class="g-font-size-13" href="https://www.news-medical.net/news/20240322/Revolutionizing-cysteine-rich-peptide-production-for-drug-discovery.aspx">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">06.</span> 
    SecM Arrest Peptide Traps Pre-Peptide Bond Formation State of the Ribosome
  </h3>
  <p>
    The SecM arrest peptide halts the ribosome before peptide bond formation, providing new insights into protein synthesis regulation and potential antibiotic targets.
  </p>
  <a class="g-font-size-13" href="https://www.nature.com/articles/s41467-024-46762-2">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">07.</span> 
    A Phage-Displayed Disulfide Constrained Peptide Discovery Platform Yields Novel Human Plasma Protein Binders
  </h3>
  <p>
    This study presents a platform for discovering novel peptide binders for human plasma proteins using phage display technology. The platform utilizes disulfide-constrained peptides, enhancing stability and binding affinity. The findings have potential implications for therapeutic development and diagnostics.
  </p>
  <a class="g-font-size-13" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0299804">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">08.</span> 
    Neuropeptide in Blood Helps Diagnose Chronic Itch
  </h3>
  <p>
    A specific neuropeptide in blood can help diagnose chronic itch conditions, potentially leading to earlier and more accurate diagnoses.
  </p>
  <a class="g-font-size-13" href="https://news.med.miami.edu/neuropeptide-in-blood-helps-diagnose-chronic-itch/">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">09.</span> 
    Newly Discovered Peptide Could Treat Incurable Bacterial Infections
  </h3>
  <p>
    A new peptide has been identified that can treat antibiotic-resistant bacterial infections, offering hope for new treatments against persistent infections.
  </p>
  <a class="g-font-size-13" href="https://scitechdaily.com/newly-discovered-peptide-could-treat-incurable-bacterial-infections/">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">10.</span> 
    Treating Obesity Using GLP-1 Directed NMDA Receptor Inhibition
  </h3>
  <p>
    GLP-1 directed NMDA receptor inhibitors are being researched as a potential obesity treatment, combining the benefits of GLP-1 therapies with fewer side effects.
  </p>
  <a class="g-font-size-13" href="https://www.news-medical.net/news/20240520/Treating-obesity-using-glucagon-like-peptide-1-directed-N-methyl-D-aspartate-receptor-inhibition.aspx">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">11.</span> 
    MORITS: An Improved Method to Predict Peptides from Heterologous Proteins that are Recognized by the Same T-Cell Receptor
  </h3>
  <p>
    The article introduces MORITS, a novel method for predicting peptides from heterologous proteins that can be recognized by the same T-cell receptor. This method could improve immunotherapy strategies by identifying cross-reactive peptides, enhancing the precision of immune responses in treatments.
  </p>
  <a class="g-font-size-13" href="https://www.nature.com/articles/s41598-024-58350-x">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">12.</span> 
    Chemokine-Derived Oncolytic Peptide Induces Immunogenic Cancer Cell Death and Significantly Suppresses Tumor Growth
  </h3>
  <p>
    Researchers developed an oncolytic peptide derived from chemokines that induces immunogenic cancer cell death. This peptide significantly suppresses tumor growth, highlighting its potential as a novel therapeutic strategy in cancer treatment. The study emphasizes the importance of immunogenic cell death in oncology.
  </p>
  <a class="g-font-size-13" href="https://www.nature.com/articles/s41420-024-01932-5">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">13.</span> 
    Drug Delivery Multifunctional Based Switchable Systems
  </h3>
  <p>
    Scientists are developing multifunctional, switchable drug delivery systems that can adapt to different therapeutic needs. These systems aim to enhance the precision and efficacy of drug delivery, reducing side effects and improving patient outcomes (Source: Phys.org).
  </p>
  <a class="g-font-size-13" href="https://phys.org/news/2024-04-drug-delivery-multifunctional-based-switchable.html">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">14.</span> 
    Extracellular Vesicles Selective Capture by Peptide-Functionalized Hollow Fiber Membranes
  </h3>
  <p>
    The Institute on Membrane Technology develops a peptide-functionalized hollow fiber (HF) membrane module for the selective capture and enrichment of extracellular vesicles (EVs) from human cardiac progenitor cells. By modifying HF membranes with a copoly azide polymer and integrating them into a tangential flow filtration (TFF) process, the researchers achieved high purity EV isolation, removing contaminants such as albumin and preserving EV structural integrity. This scalable method offers a promising approach for EV-based diagnostic and therapeutic applications.
  </p>
  <a class="g-font-size-13" href="https://www.sciencedirect.com/science/article/pii/S0021979724007938">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">15.</span> 
    Thermodynamic and Molecular Dynamic Insights into How Fusion Influences Peptide-Tag Recognition of an Antibody
  </h3>
  <p>
    This research provides insights into how peptide fusion impacts the recognition by an antibody. Thermodynamic and molecular dynamics analyses reveal changes in binding affinity and specificity. These findings are crucial for designing more effective peptide-based therapeutics and diagnostic tools.
  </p>
  <a class="g-font-size-13" href="https://www.nature.com/articles/s41598-024-59355-2">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">16.</span> 
    Imaging Technique Shows New Details of Peptide Structures
  </h3>
  <p>
    Advances in imaging technology have allowed scientists to visualize peptide structures with unprecedented detail. This breakthrough enhances the understanding of peptide interactions and can facilitate the development of new drugs and therapies (Source: X-MOL).
  </p>
  <a class="g-font-size-13" href="https://source.wustl.edu/2024/04/imaging-technique-shows-new-details-of-peptide-structures/">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">17.</span> 
    Innovative Peptide-Based Hydrogel Therapy for Virus Prevention
  </h3>
  <p>
    Researchers created a peptide-based hydrogel that can be used to prevent viral infections. This innovative approach offers a potential new method for controlling the spread of viruses and protecting public health (Source: News-Medical.net).
  </p>
  <a class="g-font-size-13" href="https://www.news-medical.net/news/20240423/Innovative-peptide-based-hydrogel-therapy-for-virus-prevention.aspx">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">18.</span> 
    Vesicle Protrusion Induced by Antimicrobial Peptides Suggests Common Carpet Mechanism for Short Antimicrobial Peptides
  </h3>
  <p>
    The study examines the mechanism by which short antimicrobial peptides induce vesicle protrusion, suggesting a common carpet mechanism. This research advances the understanding of antimicrobial peptide action, which is vital for developing new antibiotics.
  </p>
  <a class="g-font-size-13" href="https://www.nature.com/articles/s41598-024-60601-w">Read more...</a>
</div>

<div class="g-mb-60">
  <h3 class="h4 g-color-black g-font-weight-600">
    <span class="g-font-size-25">19.</span> 
    Peptide Vaccines Get an OS Update
  </h3>
  <p>
    This article discusses advancements in peptide vaccine design, focusing on thioamide substitution in the peptide backbone. This modification enhances resistance to proteolysis and improves binding to the MHC I complex, potentially increasing the efficacy of peptide vaccines.
  </p>
  <a class="g-font-size-13" href="https://www.nature.com/articles/s41589-024-01608-2">Read more...</a>
</div>


        </div>
      </div>
    </section>
    <!-- End Blog Single Item Info -->


          <!-- Social Icons -->
          <div class="text-center">
            <h3 class="h6 g-color-black g-font-weight-600 text-uppercase mb-3">Share:</h3>
            <ul class="list-inline g-mb-60">
              <li class="list-inline-item g-mx-2">
                <a class="u-icon-v1 u-icon-slide-up--hover g-color-gray-dark-v4 g-color-linkedin--hover" href="https://www.linkedin.com/sharing/share-offsite/?url=https://www.csbio.com/monthly/news-feb2024">
                  <i class="g-font-size-default g-line-height-1 u-icon__elem-regular fa fa-linkedin"></i>
                  <i class="g-font-size-default g-line-height-0_8 u-icon__elem-hover fa fa-linkedin"></i>
                </a>
              </li>
            </ul>
          </div>
          <!-- End Social Icons -->
        </div>
      </div>
    </section>
    <!-- End Blog Single Item Author -->

          <!-- Call to Action -->

<div class="shortcode-html">
    <section class="g-color-white g-bg-primary g-pa-40">
        <div class="container">
            <div class="row">
                <div class="col-md-8 align-self-center">
                    <h2 class="h3 text-uppercase g-font-weight-300 g-mb-20 g-mb-0--md">Get the <strong>top 10</strong> highlights monthly in your inbox
                    </h2>
                </div>

                <div class="col-md-4 align-self-center">
                    <!-- Begin Mailchimp Signup Form -->
                    <div id="mc_embed_signup">
                        <form action="https://csbio.us21.list-manage.com/subscribe/post?u=24a6d0fd3c6e9baad298d302c&amp;id=a5b48c4200&amp;f_id=003dece6f0" 
                              method="post" 
                              id="mc-embedded-subscribe-form" 
                              name="mc-embedded-subscribe-form" 
                              class="validate" 
                              target="_blank">

                            <div class="input-group g-brd-white--focus">
                                <input class="form-control form-control-lg g-font-size-default g-placeholder-white g-color-white g-bg-transparent g-bg-transparent--focus g-brd-white rounded-0 required email" 
                                       name="EMAIL" 
                                       type="email" 
                                       id="mce-EMAIL" 
                                       required="" 
                                       placeholder="Enter your email...">
                                <div class="input-group-append">
                                    <input type="submit" value="Subscribe" name="subscribe" id="mc-embedded-subscribe" class="button input-group-text g-color-white g-bg-transparent g-brd-white rounded-0">
                                </div>
                            </div>
                        </form>
                    </div>
                    <!--End mc_embed_signup-->
                </div>
            </div>
        </div>
    </section>
</div>
            
    <!-- End Call to Action -->
  


      <!-- Footer -->
      <div id="contacts-section" class="g-bg-black-opacity-0_9 g-color-white-opacity-0_8 g-py-60">
        <div class="container">
          <div class="row">
            <!-- Footer Content -->
            <div class="col-md-3 g-mb-40 g-mb-0--lg">
              <div class="u-heading-v2-3--bottom g-brd-white-opacity-0_8 g-mb-20">
                <h2 class="u-heading-v2__title h6 text-uppercase mb-0">About Us</h2>
              </div>
  
              <p>CSBio is a leading peptide instrumentation manufacturing company located in Silicon Valley, California. <br> <br>CSBio provides research scale peptide synthesizers, pilot scale peptide synthesizers, commerical scale peptide synthesizers, and DNA/RNA oligonucleotide synthesizers.</p>
            </div>
            <!-- End Footer Content -->
  
            <!-- Footer Content -->
  
  
            <!-- Footer Content -->
            <div class="col-md-3 g-mb-40 g-mb-0--lg">
              <div class="u-heading-v2-3--bottom g-brd-white-opacity-0_8 g-mb-20">
                <h2 class="u-heading-v2__title h6 text-uppercase mb-0">Links</h2>
              </div>
  
              <nav class="text-uppercase1">
                <ul class="list-unstyled g-mt-minus-10 mb-0">
                  <li class="g-pos-rel g-brd-bottom g-brd-white-opacity-0_1 g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../index.html">Home</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                  <li class="g-pos-rel g-brd-bottom g-brd-white-opacity-0_1 g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../researchscale.html">Research Scale Synthesizers</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                                    <li class="g-pos-rel g-brd-bottom g-brd-white-opacity-0_1 g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../pilotscale.html">Pilot Scale Synthesizers</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                                    <li class="g-pos-rel g-brd-bottom g-brd-white-opacity-0_1 g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../commercialscale.html">Commercial Scale Synthesizers</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                                    <li class="g-pos-rel g-brd-bottom g-brd-white-opacity-0_1 g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../dna.html">DNA Scale Synthesizers</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                  <li class="g-pos-rel g-brd-bottom g-brd-white-opacity-0_1 g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../blog.html">Resources</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                  <li class="g-pos-rel g-py-10">
                    <h4 class="h6 g-pr-20 mb-0">
                  <a class="g-color-white-opacity-0_8 g-color-white--hover" href="../offices.html">About</a>
                  <i class="fa fa-angle-right g-absolute-centered--y g-right-0"></i>
                </h4>
                  </li>
                </ul>
              </nav>
            </div>
            <!-- End Footer Content -->
  
            <!-- Footer Content -->

                                    <div class="col-md-3">
              <div class="u-heading-v2-3--bottom g-brd-white-opacity-0_8 g-mb-20">
                <h2 class="u-heading-v2__title h6 text-uppercase mb-0"> Contact</h2>
              </div>
  
              <address class="g-bg-no-repeat g-font-size-12 mb-0" style="background-image: url();">
            <!-- Location -->
            <div class="d-flex g-mb-20">
              <div class="g-mr-10">
                <span class="u-icon-v3 u-icon-size--xs g-bg-white-opacity-0_1 g-color-white-opacity-0_6">
                  <i class="fa fa-map-marker"></i>
                </span>
              </div>
              <p class="mb-0">915 Linda Vista Ave<br>Mountain View, CA, 94043</p>
            </div>
            <!-- End Location -->
  
            <!-- Phone -->
            <div class="d-flex g-mb-20">
              <div class="g-mr-10">
                <span class="u-icon-v3 u-icon-size--xs g-bg-white-opacity-0_1 g-color-white-opacity-0_6">
                  <i class="fa fa-phone"></i>
                </span>
              </div>
              <p class="mb-0"> <br> +1-650-525-6200<br> </p>
            </div>
            <!-- End Phone -->
  
            <!-- Email and Website -->
            <div class="d-flex g-mb-20">
              <div class="g-mr-10">
                <span class="u-icon-v3 u-icon-size--xs g-bg-white-opacity-0_1 g-color-white-opacity-0_6">
                  <i class="fa fa-globe"></i>
                </span>
              </div>
              <p class="mb-0">
                <a class="g-color-white-opacity-0_8 g-color-white--hover" href="mailto:instrument@csbio.com">instrument@csbio.com</a>
              </p>
            </div>
            <!-- End Email and Website -->
          </address>
            </div>


            <!-- End Footer Content -->
          </div>
        </div>
      </div>
      <!-- End Footer -->
  
      <!-- Copyright Footer -->
      <footer class="g-bg-gray-dark-v1 g-color-white-opacity-0_8 g-py-20">
        <div class="container">
          <div class="row">
            <div class="col-md-8 text-center text-md-left g-mb-10 g-mb-0--md">
              <div class="d-lg-flex">
                <small class="d-block g-font-size-default g-mr-10 g-mb-10 g-mb-0--md">2026 &copy; All Rights Reserved.</small>     
              </div>
            </div>
          </div>
        </div>
      </footer>
      <!-- End Copyright Footer -->

    <a class="js-go-to u-go-to-v1" href="#" data-type="fixed" data-position='{
     "bottom": 15,
     "right": 15
   }' data-offset-top="400" data-compensation="#js-header" data-show-effect="zoomIn">
      <i class="hs-icon hs-icon-arrow-top"></i>
    </a>
  </main>

  <div class="u-outer-spaces-helper"></div>

      <!-- Google Analytics -->
      <script>
      window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;
      ga('create', 'UA-62852370-1', 'auto');
      ga('send', 'pageview');
      </script>
      <script async src='https://www.google-analytics.com/analytics.js'></script>
      <!-- End Google Analytics -->

  <!-- JS Global Compulsory -->
  <script src="../assets/vendor/jquery/jquery.min.js"></script>
  <script src="../assets/vendor/jquery-migrate/jquery-migrate.min.js"></script>
  <script src="../assets/vendor/popper.js/popper.min.js"></script>
  <script src="../assets/vendor/bootstrap/bootstrap.min.js"></script>


  <!-- JS Implementing Plugins -->
  <script src="../assets/vendor/hs-megamenu/src/hs.megamenu.js"></script>
  <script src="../assets/vendor/fancybox/jquery.fancybox.min.js"></script>

  <!-- JS Unify -->
  <script src="../assets/js/hs.core.js"></script>
  <script src="../assets/js/components/hs.header.js"></script>
  <script src="../assets/js/helpers/hs.hamburgers.js"></script>
  <script src="../assets/js/components/hs.tabs.js"></script>
  <script src="../assets/js/components/hs.popup.js"></script>
  <script src="../assets/js/components/hs.go-to.js"></script>

  <!-- JS Customization -->
  <script src="../assets/js/custom.js"></script>

  <!-- JS Plugins Init. -->
  <script>
    $(document).on('ready', function () {
        // initialization of tabs
        $.HSCore.components.HSTabs.init('[role="tablist"]');

        // initialization of popups
        $.HSCore.components.HSPopup.init('.js-fancybox');

        // initialization of go to
        $.HSCore.components.HSGoTo.init('.js-go-to');
      });

      $(window).on('load', function () {
        // initialization of header
        $.HSCore.components.HSHeader.init($('#js-header'));
        $.HSCore.helpers.HSHamburgers.init('.hamburger');

        // initialization of HSMegaMenu component
        $('.js-mega-menu').HSMegaMenu({
          event: 'hover',
          pageContainer: $('.container'),
          breakpoint: 991
        });
      });

      $(window).on('resize', function () {
        setTimeout(function () {
          $.HSCore.components.HSTabs.init('[role="tablist"]');
        }, 200);
      });
  </script>


<!-- Paste the Mailchimp JS script at the bottom of your HTML file, before the closing </body> tag -->
<script type="text/javascript" src="//s3.amazonaws.com/downloads.mailchimp.com/js/mc-validate.js"></script>
<script type="text/javascript">
    (function($) {
        window.fnames = new Array(); 
        window.ftypes = new Array();
        fnames[0]='EMAIL';ftypes[0]='email';
        //... Add other fields if necessary
    }(jQuery));
    var $mcj = jQuery.noConflict(true);
</script>




</body>

</html>
